<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04697537</url>
  </required_header>
  <id_info>
    <org_study_id>GAS1.0</org_study_id>
    <nct_id>NCT04697537</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Regional Anesthesia vs Local Infiltration Anesthesia With Dexmedetomidine and Ropivacaine</brief_title>
  <official_title>Dexmedetomidine as Adjunct Medication to Local Infiltration Anesthesia (LIA) vs Ultrasound-Guided Regional Anesthesia (USRA) in Regard to Patients' Need for Opioids, Wellbeing, Satisfaction, and Knee Functionality in Knee-endoprosthetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the Impact of dexmedetomidine as an adjunct for local infiltrations analgesia&#xD;
      and ultrasound-based regional anaesthesia as pain medication in regard to patients' opioid&#xD;
      need the first 48 hours after the total knee replacement operation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of the Impact of dexmedetomidine as an adjunct for local infiltrations analgesia&#xD;
      and ultrasound-based regional anaesthesia as pain medication in regard to patients' opioid&#xD;
      need the first 48 hours after the total knee replacement operation. Secondary objectives are:&#xD;
      Pain assesment, Pain medication necessary, functionality of the prothesis, satisfaction,&#xD;
      wellbeing, postoperative discomforts, complications (delirium, allergic reactions,&#xD;
      cardiopulmonary decompensation), procedure specific time.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Actual">April 9, 2021</completion_date>
  <primary_completion_date type="Actual">April 9, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Need of opioid consumption in oral morphine equivalent</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>consumed opioids in mg of oral morphine equivalent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain assesment</measure>
    <time_frame>5 days postoperatively or until discharge</time_frame>
    <description>Pain experienced by patients according to self-assesment according to NRS (Numeric rating scale) (minimum 0, maximum 10) (higher score means worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain medication necessary</measure>
    <time_frame>5 days postoperatively or until discharge</time_frame>
    <description>Need of opioid consumption in mg of oral morphine equivalent up to the 5th postoperative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functionality of the prothesis - OKS (Oxford Knee Score)</measure>
    <time_frame>5 days postoperatively or until discharge</time_frame>
    <description>According to physical examination by the Oxford Knee Score (minimum 0, maximum 48) (higher score means better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functionality of the prothesis- KOOS (Knee Injury and Osteoarthritis Outcome Score)</measure>
    <time_frame>5 days postoperatively or until discharge</time_frame>
    <description>According to physical examination by the orthopedics score KOOS (minimum 0, maximum 100) (higher score means better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functionality of the prothesis - WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index)</measure>
    <time_frame>5 days postoperatively or until discharge</time_frame>
    <description>According to physical examination by the orthopedics score WOMAC (minimum 0, maximum 96) (higher score means worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functionality of the prothesis- G-FJS (German Forgotten Joint Score)</measure>
    <time_frame>5 days postoperatively or until discharge</time_frame>
    <description>According to physical examination by the orthopedics score G-FJS (minimum 0, maximum 100) (higher score means better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>5 days postoperatively or until discharge</time_frame>
    <description>Incidence of complications in total (e.g. delirium, allergic reactions, cardiopulmonary decompensation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>procedure specific time</measure>
    <time_frame>during surgery</time_frame>
    <description>time of the operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Anesthesia, Local</condition>
  <condition>Gonarthrosis</condition>
  <arm_group>
    <arm_group_label>Ultrasound guided regional anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will be given a peripheral nerve block from their treating anesthesiologist before the operation (in the OR) with an conventional ultrasound guided femoral and sciatic block of each 15 ml ropivacaine 0,5% and 0,5 ml dexmedetomidine (100µg/ml).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local infiltration analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will be given a local infiltration analgesia from their treating surgeon during the operation (in the OR) with 60 ml ropivacaine 0,5% and 1 ml dexmedetomidine (100µg/ml).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ultrasound guided regional anesthesia</intervention_name>
    <description>Applied perineurally preoperatively ultrasound guided regional anesthesia</description>
    <arm_group_label>Ultrasound guided regional anesthesia</arm_group_label>
    <other_name>dexmedetomidine</other_name>
    <other_name>Ropivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Local infiltration analgesia</intervention_name>
    <description>Applied in the wound intraoperatively from the orthopedics</description>
    <arm_group_label>Local infiltration analgesia</arm_group_label>
    <other_name>dexmedetomidine</other_name>
    <other_name>Ropivacaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult&#xD;
&#xD;
          -  non pregnant&#xD;
&#xD;
          -  patients with gonarthrosis who have given written consent for participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age below 18 years&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  breast-feeding patients&#xD;
&#xD;
          -  allergies against study medication&#xD;
&#xD;
          -  missing or denied written consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregor A Schittek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Med Uni Graz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University Hospital LKH Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 4, 2021</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be made available upon reasonable request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data will be made available upon reasonable request</ipd_time_frame>
    <ipd_access_criteria>Data will be made available upon reasonable request</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

